Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 36

1.

Antibiotic cross-resistance in the lab and resistance co-occurrence in the clinic: Discrepancies and implications in E.coli.

Obolski U, Dellus-Gur E, Stein GY, Hadany L.

Infect Genet Evol. 2016 Jun;40:155-61. doi: 10.1016/j.meegid.2016.02.017. Epub 2016 Feb 13.

PMID:
26883379
2.

A case of hepatotoxicity induced by adulterated "Tiger king", a Chinese herbal medicine containing sildenafil.

Nissan R, Poperno A, Stein GY, Shapira B, Fuchs S, Berkovitz R, Hess Z, Arieli M.

Curr Drug Saf. 2015 Nov 12. [Epub ahead of print]

PMID:
26560492
3.

Antibiotic Restriction Might Facilitate the Emergence of Multi-drug Resistance.

Obolski U, Stein GY, Hadany L.

PLoS Comput Biol. 2015 Jun 25;11(6):e1004340. doi: 10.1371/journal.pcbi.1004340. eCollection 2015 Jun.

4.

Predicting Clostridium difficile infection in diabetic patients and the effect of metformin therapy: a retrospective, case-control study.

Eliakim-Raz N, Fishman G, Yahav D, Goldberg E, Stein GY, Zvi HB, Barsheshet A, Bishara J.

Eur J Clin Microbiol Infect Dis. 2015 Jun;34(6):1201-5. doi: 10.1007/s10096-015-2348-3. Epub 2015 Feb 17.

PMID:
25686730
5.

Clinical implications of high-sensitivity cardiac troponin measurements in hospitalized medical patients.

Stein GY, Alon D, Korenfeld R, Fuchs S.

PLoS One. 2015 Jan 30;10(1):e0117162. doi: 10.1371/journal.pone.0117162. eCollection 2015.

6.

Phenotype-based cell-specific metabolic modeling reveals metabolic liabilities of cancer.

Yizhak K, Gaude E, Le Dévédec S, Waldman YY, Stein GY, van de Water B, Frezza C, Ruppin E.

Elife. 2014 Nov 21;3. doi: 10.7554/eLife.03641.

7.

Interaction between digoxin and dronedarone in the PALLAS trial.

Hohnloser SH, Halperin JL, Camm AJ, Gao P, Radzik D, Connolly SJ; PALLAS investigators.

Circ Arrhythm Electrophysiol. 2014 Dec;7(6):1019-25. doi: 10.1161/CIRCEP.114.002046. Epub 2014 Nov 6.

8.

Resistance profiles of coagulase-negative staphylococci contaminating blood cultures predict pathogen resistance and patient mortality.

Obolski U, Alon D, Hadany L, Stein GY.

J Antimicrob Chemother. 2014 Sep;69(9):2541-6. doi: 10.1093/jac/dku156. Epub 2014 May 22.

9.

Type-II myocardial infarction--patient characteristics, management and outcomes.

Stein GY, Herscovici G, Korenfeld R, Matetzky S, Gottlieb S, Alon D, Gevrielov-Yusim N, Iakobishvili Z, Fuchs S.

PLoS One. 2014 Jan 2;9(1):e84285. doi: 10.1371/journal.pone.0084285. eCollection 2014.

10.

Predictors and outcomes of infection-related hospital admissions of heart failure patients.

Alon D, Stein GY, Korenfeld R, Fuchs S.

PLoS One. 2013 Aug 23;8(8):e72476. doi: 10.1371/journal.pone.0072476. eCollection 2013.

11.

A method for inferring medical diagnoses from patient similarities.

Gottlieb A, Stein GY, Ruppin E, Altman RB, Sharan R.

BMC Med. 2013 Sep 2;11:194. doi: 10.1186/1741-7015-11-194.

12.

Generic atorvastatin-induced thrombocytopenic purpura: a raised red flag.

Gurevich A, Epstein L, Stein GY.

Isr Med Assoc J. 2013 Mar;15(3):197-8. No abstract available.

13.

Gender-related differences in hospitalized heart failure patients.

Stein GY, Ben-Gal T, Kremer A, Bental T, Alon D, Korenfeld R, Yedidia I, Porter A, Abramson E, Sagie A, Fuchs S.

Eur J Heart Fail. 2013 Jul;15(7):734-41. doi: 10.1093/eurjhf/hft024. Epub 2013 Feb 17.

14.

Met kinetic signature derived from the response to HGF/SF in a cellular model predicts breast cancer patient survival.

Stein GY, Yosef N, Reichman H, Horev J, Laser-Azogui A, Berens A, Resau J, Ruppin E, Sharan R, Tsarfaty I.

PLoS One. 2012;7(9):e45969. doi: 10.1371/journal.pone.0045969. Epub 2012 Sep 25.

15.

Metabolic associations of reduced proliferation and oxidative stress in advanced breast cancer.

Jerby L, Wolf L, Denkert C, Stein GY, Hilvo M, Oresic M, Geiger T, Ruppin E.

Cancer Res. 2012 Nov 15;72(22):5712-20. doi: 10.1158/0008-5472.CAN-12-2215. Epub 2012 Sep 17.

16.

The diversity of heart failure in a hospitalized population: the role of age.

Stein GY, Kremer A, Shochat T, Bental T, Korenfeld R, Abramson E, Ben-Gal T, Sagie A, Fuchs S.

J Card Fail. 2012 Aug;18(8):645-53. doi: 10.1016/j.cardfail.2012.05.007. Epub 2012 Jun 29.

PMID:
22858081
17.

INDI: a computational framework for inferring drug interactions and their associated recommendations.

Gottlieb A, Stein GY, Oron Y, Ruppin E, Sharan R.

Mol Syst Biol. 2012 Jul 17;8:592. doi: 10.1038/msb.2012.26.

18.

Sex differences in the epidemiology, seasonal variation, and trends in the management of patients with acute appendicitis.

Stein GY, Rath-Wolfson L, Zeidman A, Atar E, Marcus O, Joubran S, Ram E.

Langenbecks Arch Surg. 2012 Oct;397(7):1087-92. doi: 10.1007/s00423-012-0958-0. Epub 2012 Jun 2.

PMID:
22661078
19.

Dronedarone in high-risk permanent atrial fibrillation.

Connolly SJ, Camm AJ, Halperin JL, Joyner C, Alings M, Amerena J, Atar D, Avezum Á, Blomström P, Borggrefe M, Budaj A, Chen SA, Ching CK, Commerford P, Dans A, Davy JM, Delacrétaz E, Di Pasquale G, Diaz R, Dorian P, Flaker G, Golitsyn S, Gonzalez-Hermosillo A, Granger CB, Heidbüchel H, Kautzner J, Kim JS, Lanas F, Lewis BS, Merino JL, Morillo C, Murin J, Narasimhan C, Paolasso E, Parkhomenko A, Peters NS, Sim KH, Stiles MK, Tanomsup S, Toivonen L, Tomcsányi J, Torp-Pedersen C, Tse HF, Vardas P, Vinereanu D, Xavier D, Zhu J, Zhu JR, Baret-Cormel L, Weinling E, Staiger C, Yusuf S, Chrolavicius S, Afzal R, Hohnloser SH; PALLAS Investigators.

N Engl J Med. 2011 Dec 15;365(24):2268-76. doi: 10.1056/NEJMoa1109867. Epub 2011 Nov 14. Erratum in: N Engl J Med. 2012 Feb 16;366(7):672.

20.

Long-term response to rituximab in patients with relapsing thrombotic thrombocytopenic purpura.

Stein GY, Blickstein D, Orlin J, Sarig G, Inbal A.

Isr Med Assoc J. 2011 Jul;13(7):398-401.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk